In a study of breast cancer patients, significantly higher positive CTC detection rate was found using an EpCAM independent detection method compared to EpCAM-based detection technique (69.2% vs. 42.3%), indicating a loss of CTC detection by EpCAM-based detection technique30. The gene discussed is EPCAM; the disease is breast carcinoma.